Literature DB >> 31365064

Management of 46,XY Differences/Disorders of Sex Development (DSD) Throughout Life.

Amy B Wisniewski1, Rafael L Batista2, Elaine M F Costa2, Courtney Finlayson3, Maria Helena Palma Sircili2, Francisco Tibor Dénes4, Sorahia Domenice2, Berenice B Mendonca2.   

Abstract

Differences/disorders of sex development (DSD) are a heterogeneous group of congenital conditions that result in discordance between an individual's sex chromosomes, gonads, and/or anatomic sex. Advances in the clinical care of patients and families affected by 46,XY DSD have been achieved since publication of the original Consensus meeting in 2006. The aims of this paper are to review what is known about morbidity and mortality, diagnostic tools and timing, sex of rearing, endocrine and surgical treatment, fertility and sexual function, and quality of life in people with 46,XY DSD. The role for interdisciplinary health care teams, importance of establishing a molecular diagnosis, and need for research collaborations using patient registries to better understand long-term outcomes of specific medical and surgical interventions are acknowledged and accepted. Topics that require further study include prevalence and incidence, understanding morbidity and mortality as these relate to specific etiologies underlying 46,XY DSD, appropriate and optimal options for genitoplasty, long-term quality of life, sexual function, involvement with intimate partners, and optimizing fertility potential.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Year:  2019        PMID: 31365064     DOI: 10.1210/er.2019-00049

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  16 in total

1.  [Efficacy and safety of letrozole in treatment of male children with disorders of sex development].

Authors:  Bingqing Yu; Min Nie; Xueyan Wu; Jiangfeng Mao; Xi Wang; Wanlu Ma; Wen Ji; Qibin Huang; Rui Zhang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

2.  46,XY disorders of sex development: the use of NGS for prevalent variants.

Authors:  Qi-Gen Xie; Peng Luo; Kai Xia; Zuo-Qing Li; Zhe Xu; Cheng Su; Chun-Hua Deng
Journal:  Hum Genet       Date:  2022-06-21       Impact factor: 4.132

Review 3.  Epidemiology of Male Hypogonadism.

Authors:  Arthi Thirumalai; Bradley D Anawalt
Journal:  Endocrinol Metab Clin North Am       Date:  2022-02-08       Impact factor: 4.748

Review 4.  Disorders/Differences of Sex Development Presenting in the Newborn With 46,XY Karyotype.

Authors:  Silvano Bertelloni; Nina Tyutyusheva; Margherita Valiani; Franco D'Alberton; Fulvia Baldinotti; Maria Adelaide Caligo; Giampiero I Baroncelli; Diego G Peroni
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

5.  A novel missense mutation of NR5A1 c.46T>C (p.C16R) in a Chinese infant with ambiguous genitalia.

Authors:  Dan Zhang; Ying Xin; Ming-Yu Li; Ling-Zhe Meng; Ya-Jie Tong
Journal:  Asian J Androl       Date:  2022 Jul-Aug       Impact factor: 3.054

Review 6.  Male Hypogonadism and Disorders of Sex Development.

Authors:  Romina P Grinspon; Ignacio Bergadá; Rodolfo A Rey
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-15       Impact factor: 5.555

Review 7.  Androgen Treatment in Adolescent Males With Hypogonadism.

Authors:  Rodolfo A Rey; Romina P Grinspon
Journal:  Am J Mens Health       Date:  2020 May-Jun

Review 8.  Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide.

Authors:  Rafael Loch Batista; Berenice Bilharinho Mendonca
Journal:  Appl Clin Genet       Date:  2020-04-14

Review 9.  Applying Single-Cell Analysis to Gonadogenesis and DSDs (Disorders/Differences of Sex Development).

Authors:  Martin A Estermann; Craig A Smith
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

Review 10.  Under-reported aspects of diagnosis and treatment addressed in the Dutch-Flemish guideline for comprehensive diagnostics in disorders/differences of sex development.

Authors:  Yolande van Bever; Hennie T Brüggenwirth; Katja P Wolffenbuttel; Arianne B Dessens; Irene A L Groenenberg; Maarten F C M Knapen; Elfride De Baere; Martine Cools; Conny M A van Ravenswaaij-Arts; Birgit Sikkema-Raddatz; Hedi Claahsen-van der Grinten; Marlies Kempers; Tuula Rinne; Remko Hersmus; Leendert Looijenga; Sabine E Hannema
Journal:  J Med Genet       Date:  2020-04-17       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.